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Abstract 1 
Although the role of methionine (Met), as precursor for L-carnitine synthesis, in the 2 
regulation of lipid metabolism has been explored. Met seems to have tissue- and 3 
species-specific regulatory effect on lipid metabolism, implying that the mechanisms in 4 
Met regulation of lipid metabolism is complex and may involve the upstream regulatory 5 
pathway of lipid metabolism. The present study was performed to determine the 6 
mechanism of apoptosis signaling pathways mediating Met-induced changes of hepatic 7 
lipid deposition and metabolism in fish, and compare the differences of the mechanisms 8 
between the fish and mammals. By iTRAQ-based quantitative proteome analyses, we 9 
found that both dietary Met deficiency and excess evoked apoptosis signaling pathways, 10 
increased hepatic lipid deposition and caused aberrant hepatic lipid metabolism of yellow 11 
catfish Pelteobagrus fulvidraco. Using primary hepatocytes from P. fulvidraco, inhibition 12 
of caspase by Z-VAD-FMK blocked the apoptotic signaling pathways with a concomitant 13 
reversal of Met deficiency- and excess-induced increase of lipid deposition, indicating 14 
that apoptosis involved the Met-mediated changes of hepatic lipid metabolism. Moreover, 15 
we explored the roles of three upstream apoptotic signaling pathways (PI3K/AKT-TOR 16 
pathway, cAMP/PKA/CREB pathway and LKB1/AMPK-FOXO pathway) influencing 17 
hepatic lipid metabolism of P. fulvidraco. The three upstream pathways participated in 18 
apoptosis mediating Met-induced changes of lipid metabolism in P. fulvidraco. At last, 19 
HepG2 cell line was used to compare the similarities of mechanisms in apoptosis 20 
mediating Met-induced changes of lipid metabolism between fish and mammals. 21 
Although several slight differences existed, apoptosis mediated the Met-induced changes 22 
of lipid metabolism between fish and mammals. The present study reveals novel 23 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
3 
 
apoptosis-relevant signal transduction axis which mediates the Met-induced changes of 24 
lipid metabolism, which will help understand the mechanistic link between apoptosis and 25 
lipid metabolism, and highlight the importance of the evolutionary conservative apoptosis 26 
signaling axis in regulating Met–induced changes of hepatic lipid metabolism. 27 
Keywords: Methionine; Apoptosis; Lipid deposition; Lipid metabolism; Signaling 28 
pathway 29 
Abbreviations: 30 
AKT, RAC-alpha serine/threonine-protein kinase; AMPK, AMP-activated kinase; APO, 31 
Apolipoprotein; cAMP, Cyclic AMP; CPT-1, Carnitine palmitoyl transferase-1; CREB, Cyclic 32 
AMP-responsive element-binding protein; FAS, Fatty acid synthase; FBW, Final mean body weight; 33 
FCR, Feed conversion rate; iTRAQ, isobaric tags for relative or absolute quantitation; FI, Feed intake; 34 
FOXO, Forkhead transcription factors; HSL, Hormone sensitive lipase; LKB1, Liver kinase B1; Met, 35 
Methionine; TOR, mammalian target of rapamycin; PI3K, Phosphatidylinositol-3 kinases; PKA, 36 
Protein kinase A; SGR, Specific growth rate; TG, Triglycerides; WG, Weight gain 37 
 38 
Introduction 39 
Methionine (Met), as a principal donor of the methyl group, is required for protein synthesis and 40 
plays important roles in numerous biological processes [1]. Recently, several studies have indicated 41 
the important role of Met in lipid deposition and metabolism [2,3]. For example, Met restriction (MR) 42 
reduced lipid accumulation, and increased de novo lipogenesis, lipolysis and fatty acid oxidation [4]. 43 
Met deficiency and excess also resulted in deregulation in lipid metabolic pathways [5]. Moreover, 44 
studies suggested that Met-mediated changes in lipid metabolism were tissues- [6,7], and 45 
species-dependent[4,6,8]. Thus, the mechanisms of Met regulating lipid metabolism may be complex 46 
and the upstream regulatory pathway of lipid metabolism may be involved in. 47 
As a homeostatic mechanism to maintain cell populations in tissues, apoptosis is a highly 48 
organized and genetically controlled form of cell death. Several studies indicated that imbalanced Met 49 
could induce apoptosis both in vivo and in vitro [9,10]. Apoptosis is executed by two fundamental 50 
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pathways: the extrinsic pathway is mediated by death receptors on the cellular surface and the intrinsic 51 
pathway is organelle-based [11]. The extrinsic pathway is initiated by death receptors, including Fas, 52 
TNF receptor (R)1 and TNF-related apoptosis-inducing ligand (TRAIL) receptors. When engaged by 53 
their natural ligands, these receptors trigger intracellular cascades that activate death-inducing 54 
proteolytic enzymes, especially caspases [12]. In the intrinsic pathway, apoptosis can be initiated by 55 
several intracellular organelles. In hepatocytes, mitochondrial dysfunction plays a critical role by 56 
amplifying the apoptotic signals and integrating both pathways into the final common pathway which 57 
executes the apoptotic changes [13]. The mitochondrial events are regulated by the members of Bcl-2 58 
family which include anti-apoptotic (Bcl-2, Bcl-xL) and pro-apoptotic (Bak, Bid, Bad and Bim) 59 
members [14]. Another important organelle in which proapoptotic signals may originate is the 60 
endoplasmic reticulum (ER) [15]. In addition, studies indicate that apoptosis is regulated by several 61 
upstream regulators, including PI3K/Akt-TOR pathway, cAMP/PKA/CREB pathway and 62 
LKB1/AMPK-FOXO pathway [16-18]. Accordingly, it was reasonable to conclude that Met induces 63 
the change of lipid metabolism via upstream regulators of apoptosis. However, at present, to our 64 
knowledge, although the potential link between apoptosis and lipid metabolism has been postulated 65 
[19], the mechanism of apoptosis mediating hepatic lipid metabolism still remains unknown. Our 66 
studies might provide the basis to clarify the regulatory mechanism of Met for lipid metabolism. 67 
Lipids act as a major energy source and support various physiological, developmental and 68 
reproductive processes in animals, including fish [20]. In general, lipid homeostasis is maintained by 69 
the regulation of lipogenesis, lipolysis, β-oxidation and lipid transport, and many crucial enzymes and 70 
signaling pathways are involved in these processes [21]. Yellow catfish Pelteobagrus fulvidraco, an 71 
omnivorous freshwater fish, is widely cultured in the inland freshwater waters in several Asian 72 
countries including China for its delicious meat and high market value. However, under intensive 73 
aquaculture, excess lipid deposition in yellow catfish become more and more widespread [22], which 74 
greatly reduces its taste and economic value. Thus, it is very important to investigate the 75 
characteristics of lipid metabolism and explore the pathway for reducing lipid deposition in yellow 76 
catfish. Here, given Met is the first-limiting amino acids in some feedstuffs (such as soybean meal) for 77 
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fish [23], it is very meaningful to explore the role and mechanism of Met influencing hepatic lipid 78 
deposition and metabolism. In addition, taking into account the potential link between apoptosis and 79 
lipid metabolism, we hypothesized that upstream regulators of apoptosis mediated the Met-induced 80 
changes of lipid metabolism. To that end, as a part of our project into the mechanisms of lipid 81 
metabolism and its regulatory pathways, at first, the present study was performed to determine the 82 
mechanism of upstream regulators of apoptosis mediating Met-induced changes of hepatic lipid 83 
metabolism in fish. On the other hand, in mammals, Met-mediated lipid metabolism showed 84 
species-specific response. Thus, it is very meaningful to compare the similarities for Met-induced 85 
changes of lipid metabolism between the fish and mammals. Thus, in the present study, we also 86 
compared the results between P. fulvidraco and HepG2 cell line, a model for studying lipid 87 
metabolism in mammals [24]. 88 
 89 
Materials and methods 90 
Experimental treatments 91 
Four experiments were performed. In Exp. 1, P. fulvidraco were fed diets containing three 92 
dietary Met levels for 10 weeks, and hepatic proteomic analysis was conducted to obtain the 93 
comprehensive understanding on Met-induced changes of physiological function of yellow catfish. In 94 
Exp. 2, using primary hepatocytes of yellow catfish and Z-VAD-FMK (specific inhibitor of caspase), 95 
the mechanism by which apoptosis signals mediated Met-induced changes of hepatic lipid metabolism 96 
was investigated. In Exp. 3, LY294002 (inhibitor of PI3K pathway), H89 (inhibitor against PKA 97 
pathway) and Compound C (inhibitor against AMPK pathway) were used to explore the upstream 98 
signaling pathways of apoptosis influencing hepatic lipid metabolism in P. fulvidraco. In Exp. 4, using 99 
HepG2 cell line, we also compared the similarities in the mechanism of Met influencing lipid 100 
deposition and metabolism between fish and mammals. We assured that the present experiments 101 
followed the guidelines of Institutional Animal Care and Use Committee (IACUC) of Huazhong 102 
Agricultural University, Wuhan, China. 103 
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Exp. 1: Investigating the effect of dietary Met levels on upstream regulators of apoptosis and lipid 104 
metabolism in liver of P. fulvidraco 105 
Diet preparation. Three experimental diets were formulated with L-methionine (Sigma-Aldrich, 106 
St. Louis, MO, USA) supplemented at levels of 0, 4 and 6.9 g kg
−1
 diet at the expense of cellulose 107 
(Supplementary Table 1). Different Met contents were added to the diets, based on recent study in P. 108 
fulvidraco [25], in order to produce three dietary Met groups (Met deficiency, adequate Met and Met 109 
excess, respectively). The formulation of the experimental diets was according to Wei et al. [22]. Final 110 
Met concentrations in the experimental diets were analyzed in triplicate using an automatic amino acid 111 
analyser (Hitachi L-8900, Tokyo, Japan), and the contents were 10.2 (Met deficiency), 13.1 (adequate 112 
Met), and 16.3 (Met excess) mg Met kg
−1
 diet, respectively. 113 
Experimental procedures. Yellow catfish were cultured in a semi-static aquarium system 114 
according to our published protocol [22]. Briefly, 270 uniform-sized fish (mean weight: 1.79 ± 0.02g, 115 
mean ± SEM) were stocked in 9 fiberglass tanks (300-l in water volume), 30 fish per tank. Each diet 116 
was distributed randomly to triplicate tanks. At the termination of the feeding experiment (10 wks), 117 
hepatic proteome profiles of P. fulvidraco and other relevant indicators were determined. 118 
Exp. 2: Determining the involvement of upstream regulators of apoptosis in Met-induced change of 119 
hepatic lipid metabolism in P. fulvidraco in vitro 120 
Primary hepatocytes were isolated from P. fulvidraco liver according to our recent studies [22,26]. 121 
Firstly, P. fulvidraco was cleared of blood by cutting off the branchial arch, and disinfected with 75% 122 
alcohol. After all the blood had been cleared, the liver was carefully excised from the abdominal 123 
cavity, transferred onto a plastic petri dish, and rinsed twice with PBS supplemented with 124 
amphotericin-B (25 µg/ml), streptomycin (100 µg/ml) and penicillin (100 IU/ml). Then the liver was 125 
aseptically minced into 1 mm
3
 pieces with scalpel and scissors, and the tissue was digested by 0.25% 126 
sterile trypsin at room temperature on a shaker for 30 min, neutralized with M199 medium containing 127 
10% FBS every 5 min. The cell suspension was gathered. Then, the isolated hepatocytes were filtered 128 
through nylon sieves. Hepatocytes were collected in 15-ml sterilized centrifuge tubes, centrifuged at 129 
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low-speed (100 × g, 5 min), and washed twice with PBS for debris removal. Finally, the purified 130 
hepatocytes were resuspended with M199 medium containing 1 mmol/l L-glutamine, 5% (v/v) FBS, 131 
penicillin (100 IU/ml) and streptomycin (100 µg/ ml). Cells were counted using a hemocytometer 132 
based on the trypan blue exclusion method, and only those cultures with more than 95% cell viability 133 
were used for the subsequent experiments. For each cell culture, a pool of cells from three fish was 134 
used.  135 
To explore the role of upstream regulators of apoptosis in Met-induced changes of lipid 136 
metabolism, primary hepatocytes were treated with 50 µM Z-VAD-FMK in RPMI 1640 medium 137 
containing different Met levels. For this experiment, eight groups were designed: control (containing 138 
0.1% DMSO), Z-VAD-FMK (50 μM), Met deficiency (10 mM), adequate Met (100 mM), Met excess 139 
(1000 mM), Met deficiency (10 mM) + Z-VAD-FMK (50 μM), adequate Met (100 mM) + 140 
Z-VAD-FMK (50 μM), and Met excess (1000 mM) + Z-VAD-FMK (50 μM). Each treatment was 141 
performed in triplicate. The inhibitors were added 2 h before the addition of Met. The diagram for in 142 
vitro experiment was shown in Supplementary Fig. 1. The concentrations of Met and the specific 143 
inhibitors were selected according to previous experiments [27], our pilot trials and serum Met 144 
concentration in P. fulvidraco (91.24 ± 3.41 mM, unpublished data). Total Met concentration in the 145 
medium is of physiological relevance compared with that in P. fulvidraco. Sampling occurred at 48-h 146 
incubation. 147 
Exp. 3: Exploring the upstream regulators of apoptosis participating in Met-induced changes of 148 
hepatic lipid metabolism in P. fulvidraco in vitro 149 
In Exp. 3, specific inhibitors LY294002 (1 μM), H89 (30 μM) and Compound C (2 μM) were 150 
used to explore the roles of PI3K/AKT-TOR, CAMP/PKA/CREB and LKB1/AMPK-FOXO pathways 151 
in apoptosis influencing hepatic lipid metabolism. For PI3K/AKT-TOR pathway, eight groups were 152 
designed: control (containing 0.1% DMSO), LY294002 (1 μM), Met deficiency (10 mM), adequate 153 
Met (100 mM), Met excess (1000 mM), Met deficiency (10 mM) + LY294002 (1 μM), adequate Met 154 
(100 mM) + LY294002 (1 μM), and Met excess (1000 mM) + LY294002 (1 μM). Each treatment was 155 
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performed in triplicate. For CAMP/PKA/CREB and LKB1/AMPK-FOXO pathways, the treatments 156 
were similar with PI3K/AKT-TOR pathway. Each treatment was performed in triplicate. The diagram 157 
for in vitro experiment was shown in Supplementary Fig. 1. The concentrations of the specific 158 
inhibitors were selected according to our recent studies and preliminary experiment in P. fulvidraco 159 
[22,26,28]. The cells were collected for analysis at the 48-h incubation. 160 
Exp. 4: Comparing the similarities in the mechanism of upstream regulators of apoptosis mediating 161 
Met-induced changes of hepatic lipid metabolism between fish and mammals 162 
Using HepG2 cells line, specific inhibitors (Z-VAD-FMK, LY294002, H89 and Compound C) 163 
were used to compare the similarities in the process of upstream regulators of apoptosis mediating 164 
Met-induced changes of hepatic lipid metabolism between fish and mammals, in RPMI 1640 medium 165 
containing different levels of Met (Met deficiency, 5 mM; adequate Met, 50 mM; Met excess, 500 166 
mM). The experiment protocols were similar with those in the in vitro experiment. For example, in 167 
Z-VAD-FMK experiment, there were 8 treatment groups : control (containing 0.1% DMSO), 168 
Z-VAD-FMK (50 μM), Met deficiency (5 mM), adequate Met (50 mM), Met excess (500 mM), Met 169 
deficiency (5 mM) + Z-VAD-FMK (50 μM), adequate Met (50 mM) + Z-VAD-FMK (50 μM), and 170 
Met excess (500 mM) + Z-VAD-FMK (50 μM). Each treatment was performed in triplicate. The 171 
diagram for in vitro experiment was shown in Supplementary Fig. 1. The Met concentration was 172 
selected according to normal human serum Met concentration [29]. The concentrations of specific 173 
inhibitors were based on our previous experiments [22,26,28] and reports on mammals in vitro [30]. 174 
Sampling occurred at 48-h treatment. 175 
Sample analysis 176 
iTRAQ sample preparation, LC-MS/MS and data analysis 177 
iTRAQ sample preparation 178 
iTRAQ sample preparation was performed according to the methods described previously [31]. 179 
Briefly, three frozen liver tissues from each of the nine subgroups were homogenized on ice, with 100 180 
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g of homogenate from each used for proteomic screening. Protein lysates were obtained using lysis 181 
buffer (7 M urea, 2 M thiourea, and 1% cocktail proteinase inhibitor) followed by centrifugation at 182 
12,000 rpm for 60 min at 4 °C to remove cellular debris. Protein concentrations were established using 183 
a Bradford assay, with protein samples (250 μg) digested with trypsin solution overnight at 37 °C and 184 
labeled with iTRAQ reagents (10-plex; AB SCIEX, Massachusetts, USA) as follows: Met 185 
deficiency-1 (115N tag), Met deficiency-2 (115C tag), Met deficiency-3 (116N tag), adequate Met-1 186 
(116C tag), adequate Met-2 (117N tag), adequate Met-3 (117C tag), Met excess-1 (118N tag), Met 187 
excess-2 (118C tag), Met excess-3 (119 tag) according to the manufacturer's instructions. Then, 188 
typically peptides labeled with 10-plex iTRAQ tags were pooled and dried.  189 
The peptides were separated on a Shimadzu LC-20AB HPLC Pump system coupled with a high 190 
pH RP column. The peptides were reconstituted with buffer A (5% ACN, 95% H2O, pH 9.8) to 2 ml 191 
and loaded into a column containing 5-μm particles (Phenomenex). The peptides were separated at a 192 
flow rate of 1 mL/min with a gradient of 5% buffer B (5% H2O, 95% ACN, pH 9.8) for 10 min, 5-35% 193 
buffer B for 40min, 35-95% buffer B for 1 min. The system was then maintained in 95% buffer B for 194 
3 min and decreased to 5% within 1 min before equilibrating with 5% buffer B for 10 min. Elution 195 
was monitored by measuring absorbance at 214 nm, and fractions were collected every 1 min. The 196 
eluted peptides were pooled as 20 fractions and vacuum-dried. 197 
LC-MS/MS and data analysis 198 
The mass spectrometry analysis was performed as described in Michalski et al [32], using 199 
Q-Exactive mass spectrometer (Thermo Fisher Scientific, San Jose, CA), coupled with LC-20AD 200 
(Shimadzu). The parameters for MS analysis were listed below: electrospray voltage: 1.6 kV; 201 
precursor scan range: 300−1600 m/z at a resolution of 35,000 in Orbi trap; MS/MS fragment scan 202 
range: >100 m/z at a resolution of 70,000 in HCD mode; normalized collision energy setting: 30%; 203 
dynamic Exclusion time: 15 s; Automatic gain control (AGC) for full MS target and MS2 target: 3e6 204 
and 1e5, respectively; The number of MS/MS scans following one MS scan: 20 most abundant 205 
precursor ions above a threshold ion count of 20000. Each of the 20 high pH RP-HPLC fractions was 206 
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re-suspended in buffer A (2% ACN and 0.1% FA in water) and centrifuged at 20,000 g for 10 min. The 207 
supernatant was loaded into a C18 trap column 5 μL/min for 8min using a LC-20AD nano-HPLC 208 
instrument (Shimadzu, Kyoto, Japan) by the autosampler. Then, the peptides were eluted from trap 209 
column and separated by an analytical C18 column (inner diameter 75 μm) packed in-house. The 210 
gradient was run at 300 nL/min starting from 8% to 35% of buffer B (2% H2O and 0.1% FA in ACN) 211 
in 35 minutes, then going up to 60% in 5 minutes and to 80% of buffer B for 5 minutes, and finally 212 
return to 5% in 0.1 min and equilibrated for 10min.  213 
The software IQuant was used to quantify the labeled peptides with isobaric tags. To assess the 214 
confidence of peptides, the PSMs were pre-filtered at a PSM-level false discovery rate (FDR) of 1%. 215 
Then, based on the "simple principle" (the parsimony principle), identified sequences of peptide were 216 
assembled into a set of confident proteins. In order to control the rate of false-positive at protein level, 217 
a protein FDR at 1%, which was based on Picke protein FDR strategy, was estimated after protein 218 
inference (Protein-level FDR ≤ 0.01). The process for protein quantification included the following 219 
steps: Protein identification, Tag impurity correction, Data normalization, Missing value imputation, 220 
Protein ratio calculation, Statistical analysis, Results presentation. The transcriptome data of liver from 221 
yellow catfish was used for the peptide-protein matching. 222 
Three biological replicates were set for better coverage of the target proteome with reliable 223 
statistical consistency. The Paragon database search algorithm and an integrated FDR analysis were 224 
implemented in the ProteinPilot software for peptide identification. A 95% confidence interval (CI) 225 
was set as the significant threshold for protein identification. Quality control (QC) was performed to 226 
determine if a re-analysis step was needed. All the proteins with a FDR less than 1% proceeded with 227 
downstream analysis including GO, COG and Pathway. Furthermore, we also performed in depth 228 
analysis based on differentially expressed proteins, including Gene Ontology (GO) enrichment 229 
analysis, KEGG pathway enrichment analysis and cluster analysis. The protein lists from the 20 230 
LC-MS/MS runs, obtained by fractionation of the iTRAQ pooled sample, were merged. The 231 
confidence level of each differentially expressed protein was calculated as a p-value using ProteinPilot, 232 
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allowing the results to be evaluated, not only based on the magnitude of the change but also on the 233 
confidence level of the change. GO was performed using the bioinformatics analysis tool DAVID 234 
(http://david.abcc.ncifcrf.gov) to determine the functional classifications of the iTRAQ-identified 235 
proteins. The diagram for iTRAQ sample preparation, LC-MS/MS and data analysis was shown in 236 
Supplementary Fig. 2. 237 
Histological, histochemical and ultrastructural analyses 238 
Histological, histochemical and ultrastructural analyses were performed according to the method 239 
described in our studies [33,34]. Briefly, for histological observation, samples were dehydrated in 240 
graded ethanol concentrations and embedded in paraffin wax. Sagittal sections of 6–8 µm thickness 241 
were stained with hematoxylin–eosin (H&E) and then prepared for light microscopy. For 242 
histochemical observation, specimens were sectioned (8 µm) on a cryostat microtome. Sections were 243 
fixed in cold 10% buffered formalin for 10 min, stained with oil-red O and then prepared for light 244 
microscopy. For statistics of relative areas for hepatic vacuoles in H&E, lipid droplets in oil-red O 245 
staining, we randomly examined 10 microscope fields for each sample and the results from individual 246 
observation were then combined for the overall results. All the images were evaluated by double-blind 247 
method. For ultrastructural observation, specimens were prefixed in glutaraldehyde solution, followed 248 
by rinses with phosphate buffer. Post-fixation occurred in aqueous osmium tetroxide. After rinsing 249 
with phosphate buffer again, the specimens were dehydrated in a graded ethanol and then embedded in 250 
Epon 812 prepared for electron microscope. Ultrastructural preparations were randomly examined 251 
with 10 microscope fields for each sub-samples, and the results from each observation were then 252 
combined for the overall results. 253 
Determination of TG, APO-A1 and APO-B contents, and lipometabolic enzymatic activities  254 
TG was determined by glycerol-3-phosphate oxidase p-aminophenol (GPO-PAP) methods 255 
following Song et al. [34], using a commercial kit from Nanjing Jiancheng Bioengineering Institute, 256 
Nanjing, China. The TG content was expressed as mmol TG per mg cellular protein. 257 
Apo-A1 and APO-B levels were determined with a standard commercial immunoturbidimetric 258 
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assay following the method of Mount et al. [35]. 259 
HSL activity was determined as described by Reynisdottir et al. [36], using 260 
1(3)-[3H]-oleoyl-2-O-oleylglycerol as substrate. All samples were incubated in triplicate at 25 °C for 261 
30 min on one occasion. The substrate for HSL had only one hydrolyzable ester bond at the 1(3) 262 
position and was therefore not a substrate for MGL. Furthermore, under the present incubation 263 
conditions (pH 7.0 and no apolipoprotein CII present), lipoprotein lipase activity is negligible. In 264 
addition, HSL hydrolyzes tri- and diacylglycerol at the relative rate of 1:10. Therefore, the sensitivity 265 
of the assay is enhanced by the use of a diacylglycerol analog as substrate. One unit of enzyme activity 266 
equals 1 mmol fatty acid produced/min at 25 °C. 267 
For the determination of FAS activity, liver or hepatocytes samples were homogenized in ice-cold 268 
buffer (0.02 M Tris–HCl, 0.25 M sucrose, 2 mM EDTA, 0.1 M sodium fluoride, 0.5 mM phenyl 269 
methyl sulphonyl fluoride, 0.01 Mb-mercapto-ethanol, pH 7.4), and centrifuged at 20,000 × g at 4 °C 270 
for 30 min. The supernatant was collected and immediately used for the enzyme analysis. FAS activity 271 
was determined according to the method of Chakrabarty and Leveille [37]. One unit of enzyme 272 
activity (IU), defined as the amount of enzyme that converted 1μmol of substrate to product per min at 273 
25 °C, was expressed as units per milligram (mg) of soluble protein. 274 
For CPT-1 activity assay, mitochondria were isolated from liver or hepatocytes according to 275 
Morash et al. [38]. CPT-1 activity was determined using the method of Bieber and Fiol [39], based on 276 
measurement of the initial CoA-SH formation by the 5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB) 277 
reaction from palmitoyl-CoA by mitochondrial samples withL-carnitine at 412 nm. One unit (IU) of 278 
CPT-1 activity was defined as 1μmol of product formed per min per mg of mitochondrial protein at 279 
25 °C. 280 
Soluble protein concentration of homogenates was determined by the method of Bradford [40] 281 
using bovine serum albumin (BSA) as standard. These analyses were conducted in triplicate. 282 
Determination of caspases-3 and -9 activities 283 
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Cytosolic caspases-3 and -9 activities were determined spectrofluorometrically at 460 nm using 284 
380-nm excitation wavelength at 37°C for 150 seconds for caspase-3, and 20 minutes for caspase-9, as 285 
described by Khurana et al. [41]. 286 
Assay of cAMP, PKA and pAMPK levels 287 
cAMP and PKA levels were performed according to the methods described previously [42], using 288 
the direct cAMP and PKA ELISA kit (Enzo Life Sciences). Concentrations of phospho-AMPK (cat. 289 
number KHO0651) were determined by ELISA (Invitrogen, Camarillo, CA, USA) according to the 290 
manufacturer's instructions [43]. 291 
Annexin V and PI staining method 292 
The appearance of phosphatidyl-serine on the extracellular side of the cell membrane was 293 
quantified by Annexin V/PI staining following the method of Sheng et al. [44]. Cells were stained with 294 
Annexin V-FITC and Pl at room temperature as recommended by the manufacturer. Cells were 295 
subjected to fluorescence-activated cell sorting (FACS) analysis using a flow cytometer with apoptotic 296 
cells being Annexin V-positive/PI-negative. 297 
Terminal Transferase-Mediated dUTP Nick End Labeling (TUNEL) assay 298 
TUNEL staining was conducted using in vitro Cell Death Detection Kit (TdT-FragEL
TM
 DNA 299 
Fragmentation Detection Kit, Cat. No.: QIA33, Calbiochem, Merck, USA), used either fluorescein or 300 
alkaline phosphatase (AP) as recommended by the supplier according to manufacturer’s procedures 301 
[45]. 302 
Flow cytometric analysis 303 
For flow cytometric analysis, a FACSort (Becton Dickinson, Sunnyvale, CA) equipped with a 304 
single Argon ion laser was used according to the methods described previously [46]. Excitation was 305 
done at 488 nm and the emission filters used were 515-545 BP (green; FITC) and 600 LP (red; PI). A 306 
minimum of 5000 cells per sample were analysed. Electronic compensation was used to eliminate 307 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
14 
 
bleed through of fluorescence. Data analysis was performed with the standard Lysis and Cellfit 308 
software (Becton Dickinson). 309 
mRNA abundance determination by real-time quantitative PCR (Q-PCR) 310 
Analyses on gene transcript levels were conducted by Q-PCR method described in our studies 311 
[34]. For Q-PCR analysis, three replicate tanks and three fish for each tank were sampled for gene 312 
expression. Q-PCR was performed in a 20 μl reaction mixture including 10 μl SYBR Premix Ex 313 
TaqTM II, 0.4 μl each primer, 1μl diluted first-strand cDNA product and 8.2 μl ddH2O. Reactions 314 
were based on a three-step method as followed: at 95 °C for 30 s, 40 cycles of 5 s at 95 °C, 10 s at 315 
57 °C and 30 s at 72 °C. All reactions were performed in duplicate and each reaction was verified to 316 
contain a single product of the correct size by agarose gel electrophoresis. A non-template control and 317 
dissociation curve were performed to ensure that only one PCR product was amplified and that stock 318 
solutions were not contaminated. Standard curves were constructed for each gene using serial dilutions 319 
of stock cDNA. The amplification efficiencies of all genes were approximately equal and ranged from 320 
98 to 103 %. A set of eight common housekeeping genes (β-actin, 18s-rRNA, GAPDH, RPL7, HPRT, 321 
B2M, UBCE and TUBA) were selected from our transcriptome database for P. fulvidraco, and also 322 
selected from GenBank for HepG2 cell in order to test their transcription stability. Our pilot 323 
experiment indicated that β-actin and TUBA (β-actin and GAPDH, M=0.27) showed the most stable 324 
level of expression across the experimental conditions as suggested by geNorm [47]. Thus, the relative 325 
expression levels were normalized to the geometric mean of the combination of two genes and 326 
calculated using the 2
−ΔΔCt
 method [48].  327 
Western Blotting 328 
     For Western blotting analysis, cells were plated in 6-well plates, incubated overnight, and 329 
subsequently treated with PBS, GCRV, or poly (I:C). At 48-h posttreatment, cells were washed with 330 
PBS and lysed in lysis buffer supplemented with 1 mM phenylmethylsulfonyl fluoride, 331 
serine/threonine phosphatase inhibitor, tyrosine phosphatase inhibitor, and protease inhibitor PMSF. 332 
After clarification by centrifugation at 12,000 rpm for 15 min, 30 μg of supernatant proteins was 333 
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separated by 8-12% SDS-PAGE. The separated polypeptides were electroblotted onto nitrocellulose 334 
(NC) filter membranes (Millipore) using a trans-blot SD semidry electrophoretic transfer cell (Jim-X, 335 
Dalian, China), and then the blotted membranes were incubated with blocking TBST buffer (0.5 M 336 
Tris-Cl, 150 mM NaCl, 0.5% Tween 20, and 1% bovine serum albumin) at room temperature for 2 h. 337 
Subsequently, the membranes were incubated with appropriate primary antibodies for 2 h at room 338 
temperature in blocking TBST buffer, washed thrice with TBST buffer, and then incubated with 339 
secondary antibody for 1 h at room temperature. After again washing thrice with TBST buffer, the NC 340 
membranes were scanned and imaged by an Odyssey® CLx Imaging System (LI-COR). For 341 
hybridization, the anti-p-Akt and anti-GAPDH antisera were diluted 1:1,000, commercial primary 342 
antibodies 1:5,000, and secondary antibodies 1:10,000. 343 
Statistical analysis 344 
All data were expressed as mean ± standard error of means (SEM). Prior to statistical analysis, an 345 
arcsine transformation was used before processing percentage data. All data were tested for normality 346 
of distribution using the Kolmogorov–Smirnov test. The homogeneity of variances among the 347 
different treatments was tested using the Bartlett’s test. Then, data were subjected to one-way 348 
ANOVA and Tukey’s multiple range test using SPSS 19.0 software, and the minimum significant 349 
level was set at P< 0.05. Differences between adequate Met groups and imbalanced Met groups in the 350 
in vivo study were analyzed by Student’s T-test for independent samples. 351 
 352 
Results 353 
Growth performance and feed utilization 354 
Survival and feed intake (FI) showed no significant differences among three treatments. Compared 355 
to adequate Met, dietary Met deficiency and excess significantly decreased final mean body weight 356 
(FBW), weight gain (WG) and specific growth rate (SGR), and significantly increased feed 357 
conversion rate (FCR) (Supplementary Table 2). 358 
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Overview of Quantitative Proteomics Analysis in liver of P. fulvidraco  359 
Overall, 22,217 unique peptides corresponding to 4,554 proteins were identified (Supplementary 360 
Fig. 3A). In terms of protein mass distribution and peptide length distribution, good coverage (more 361 
than 90% of the total proteins) was obtained for proteins larger than 10 kDa (Supplementary Fig. 3B). 362 
MS raw files have been submitted to ProteomeXchange (accession number: PXD007696). 363 
For COG annotations, proteins were functionally classified into 24 COG categories. Among these 364 
categories, most enriched terms were “General function of prediction only” (Supplementary Fig. 3F). 365 
The GO annotations of biological processes revealed several proteins implicated in metabolic process 366 
and in the regulation of cellular processes (Supplementary Fig. 3G). The information of differentially 367 
expressed protein in all groups were shown in Supplementary Fig. 4. 368 
Dietary Met deficiency or excess activated upstream regulators of apoptosis and caused aberrant 369 
lipid metabolism in liver of P. fulvidraco 370 
A global understanding of the effect of dietary Met deficiency or excess on signaling pathways and 371 
hepatic lipid metabolism 372 
A 1.2-fold (P < 0.05) cut-off was used to implicate significant changes in the abundance of 373 
differentially expressed proteins (DEPs) among three Met groups. There were a total of 796 proteins 374 
identified as DEPs, 412 of which were increased and 384 were decreased in Met deficiency vs 375 
adequate Met groups (Fig. 1A and B); 842 proteins identified as DEPs, and 442 proteins were 376 
increased and 400 were decreased in Met excess vs adequate Met groups (Fig. 1D and E).  377 
Statistics of pathway enrichment indicated that dietary Met deficiency or excess posed significant 378 
effects on biological pathways, such as signal transduction, apoptosis and lipid metabolism (Fig. 1C 379 
and F). Among signal transduction pathways, three important pathways, including PI3K/AKT-TOR 380 
pathway, cAMP/PKA/CREB pathway and LKB1/AMPK-FOXO pathway, were enriched in both Met 381 
deficiency and Met excess groups (Supplementary Table 3). The majority of proteins involved in 382 
apoptosis were increased following dietary Met deficiency or excess. These DEPs participated in lipid 383 
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metabolism, including lipogenesis, lipolysis, β-oxidation and lipid transport. Several crucial proteins 384 
in lipid metabolism were differentially regulated by dietary Met deficiency or excess (Supplementary 385 
Table 3). 386 
Effect of dietary Met levels on upstream regulators of apoptosis in liver of P. fulvidraco 387 
As shown in Fig. 2B, dietary Met deficiency up-regulated the mRNA abundance of lkb1, 388 
ampka1, ampkb1 and foxo3a (LKB1/AMPK-FOXO pathway); dietary Met excess up-regulated the 389 
mRNA abundance of genes involved in cAMP/PKA/CREB pathway, and down-regulated the mRNA 390 
abundance of genes involved in PI3K/AKT-TOR pathway. 391 
Compared to dietary adequate Met, both dietary Met deficiency and excess up-regulated the 392 
mRNA abundance of genes in death receptor pathway, ER stress pathway and mitochondrial pathway 393 
(Fig. 2C), and also increased the activities of caspase-3 and -9, indicating the occurrence of apoptosis 394 
(Fig. 2D). Additionally, as shown in Fig. 2A, dietary Met deficiency and excess caused chromatin 395 
margination and nuclear convolution in hepatocytes of P. fulvidraco. 396 
Effect of dietary Met deficiency or excess on lipid metabolism in liver of P. fulvidraco 397 
First, the amount of vacuoles in H&E and lipid droplets in oil-red O increased in imbalanced 398 
dietary Met groups (Fig. 3A). The relative areas for hepatic vacuoles in H&E staining and for lipid 399 
droplets in oil-red O staining, and the TG concentrations further supported the results (Fig. 3B and C). 400 
However, dietary Met deficiency and excess had different effects on lipogenesis, lipolysis, oxidation 401 
and lipid transport: dietary Met deficiency down-regulated the mRNA abundance of hsl2, atgl, fatp4, 402 
apoa-1, apob and lpl, and HSL activity, and contents of APO-A1 and APO-B; dietary Met excess 403 
down-regulated the mRNA abundance of cpt-1, acadm, echs1, fatp4, apoa-1, apob and lpl, and CPT-1 404 
activity, and contents of APO-A1 and APO-B, up-regulated the mRNA abundance of fas, scd1, acca, 405 
and FAS activity (Fig. 3D, E, F and G). The results of genes transcription involving in lipid 406 
metabolism were further confirmed by cluster analysis (Supplementary Fig. 6). 407 
Upstream regulators of apoptosis mediated the Met-induced changes of hepatic lipid metabolism in 408 
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P. fulvidraco 409 
Compared to single Met deficiency or excess treatment, pretreatment of Z-VAD.FMK markedly 410 
attenuated the Met deficiency- and excess-induced increase of the FITC+/PI+ positive rate, apoptosis 411 
index, and rates of apoptosis (Fig. 4A, B, C and D). At the transcriptional level, the increase in mRNA 412 
abundance of proapoptotic genes and the reduction in mRNA abundance for antiapoptotic genes 413 
induced by Met deficiency or excess were alleviated by Z-VAD.FMK incubation (Fig. 4E). In addition, 414 
Z-VAD.FMK incubation also reduced the activities of caspase-3 and -9 (Fig. 4F). These results 415 
indicated that Met deficiency or excess-induced apoptosis was significantly attenuated by 416 
Z-VAD.FMK incubation. 417 
Compared to the single Met deficiency group, Z-VAD.FMK pretreatment markedly alleviated the 418 
Met deficiency-induced reduction of lipolysis and lipid transport (Fig. 4). Met excess-induced 419 
elevation of lipogenesis, and reduction of oxidation and lipid transport were also significantly 420 
attenuated by Z-VAD.FMK incubation. Furthermore, along with apoptosis attenuation, Z-VAD.FMK 421 
also significantly attenuated the Met deficiency- and excess-induced elevation of TG contents (Fig. 422 
4J).  423 
Three distinct upstream regulators of apoptosis were involved in Met-induced changes of hepatic 424 
lipid metabolism in P. fulvidraco 425 
As shown in Supplementary Fig. 7, about PI3K/AKT-TOR pathway, compared to the single Met 426 
excess group, LY294002 pretreatment and then excess Met incubation reduced the mRNA abundance 427 
of pi3kca, akt, torc1 and sgk-1, and the protein levels of p-Akt, and enhanced the mRNA abundance of 428 
casp3, casp9, chop and bax, apoptosis index, and activities of caspase-3 and -9. Meanwhile, 429 
LY294002 markedly up-regulated the Met excess-induced increase of TG content. However, 430 
interestingly, we also found that wortmannin, another inhibitor of PI3K/AKT, hd opposite effect on 431 
apoptosis and Met-induced changes of hepatic lipid metabolism, which implying that wortmannin 432 
treatment may reduce apoptotic rate or caspase activity independent of PI3Kinase (Supplementary Fig. 433 
7, 9, 12, 14). About cAMP/PKA/CREB pathway, pretreatments with H89 showed similar effect with 434 
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Wortmannin incubation. Pretreatments with H89 significantly influenced these parameters from Met 435 
excess groups, but had no significant effect on Met deficiency groups (Supplementary Fig. 8). 436 
Regarding the LKB1/AMPK-FOXO pathway (Fig. 5), pre-incubation with Compound C followed by 437 
Met incubation alleviated the Met deficiency-induced increase of apoptosis rates, activities of 438 
caspase-3 and -9, and the mRNA abundance of casp3, casp9, chop and bax. Compound C also 439 
significantly influenced the Met deficiency-induced reduction of lipolysis and lipid transport. However, 440 
although Compound C shown suppressive effect on Met excess-induced increase of apoptosis rates, 441 
activities of caspase-3 and -9, there are no statistically significant difference between Met excess and 442 
Met excess plus Compound C groups. 443 
Similarities existed in apoptosis mediating the Met-induced changes of hepatic lipid metabolism 444 
between fish and mammals 445 
At first, the roles of upstream regulators of apoptosis participating in the Met-induced changes of 446 
hepatic lipid metabolism were explored in HepG2 cells line (Fig. 6). Both Met deficiency and excess 447 
up-regulated apoptosis as evidenced by the FITC+/PI+ positive rate, apoptosis index, rates of 448 
apoptosis, activities of caspase-3 and -9 and the mRNA abundance of marker genes involved in 449 
apoptosis. The Met deficiency- and excess-evoked apoptosis was significantly attenuated by 450 
Z-VAD.FMK pretreatment. Furthermore, Met deficiency had significant effect on lipolysis, oxidation 451 
and lipid transport; Met excess showed significant effect on lipogenesis, lipolysis, oxidation and lipid 452 
transport. Additionally, Met deficiency and excess caused TG accumulation, which was also markedly 453 
alleviated by Z-VAD.FMK in HepG2 cells line. 454 
As shown in Supplementary Fig. 12, 13, LY294002 pretreatment markedly up-regulated Met 455 
deficiency- and excess- induced apoptosis by inhibiting PI3K/AKT-TOR pathway. LY294002 456 
down-regulated the levels of p-Akt and up-regulated activities of caspase-3 and -9, and TG content. 457 
Regarding the cAMP/PKA/CREB pathway, pretreatments with H89 had significant effect on these 458 
parameters only from the Met deficiency group, but not these caused by Met excess. In addition, H89 459 
pretreatment had similar effect to LY294002 pretreatments in HepG2 cells line with Met treatment. 460 
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 461 
Discussion 462 
Recently, studies about the potential role of Met in lipid metabolism at transcription levels were 463 
reported [4]. Compared with genome and transcriptome, proteome provided a more realistic picture 464 
about the underlying mechanism of Met mediating lipid metabolism. In this study, pathway 465 
enrichment analysis indicated that Met deficiency- and excess- posed significant effects on biological 466 
pathways, such as signal transduction, apoptosis and lipid metabolism. Hence, we proposed that 467 
upstream regulators of apoptosis were responsible for disturbances in hepatic lipid metabolism caused 468 
by imbalance Met, and dietary Met deficiency or excess disrupted hepatic lipid metabolism by 469 
influencing processes of lipogenesis, lipolysis, oxidation and lipid transport, which in turn caused lipid 470 
accumulation in the liver of P. fulvidraco, in agreement with other studies [5]. Similarly, Zhou et al. [4] 471 
pointed out that Met restriction (MR) increased de novo lipogenesis, lipolysis and fatty acid oxidation, 472 
with a reduction of fat accumulation. Interestingly, the present study suggested that dietary Met 473 
deficiency and excess had differential effects on the hepatic lipid metabolism in P. fulvidraco: (i) 474 
dietary Met deficiency reduced lipolysis and lipid transport; and (ii) dietary Met excess reduced 475 
oxidation and lipid transport pathway, and increased lipogenesis, in partial agreement with other 476 
studies [49]. On the other hand, our study showed that both dietary Met deficiency and excess 477 
activated upstream regulators of apoptosis in liver of P. fulvidraco, in agreement with reports in 478 
mammals [9,10]. Apoptosis will occur when the cells lack a specific nutrient [10]. In the present study, 479 
proteome analyses showed that both dietary Met deficiency and excess led to significant changes in 480 
the expression of proteins involved in upstream regulators of apoptosis. Meantime, at the 481 
transcriptional level, both dietary Met deficiency and excess had significant effect on mRNA 482 
transcription of all the tested apoptosis marker genes. The present study also indicated that both 483 
dietary Met deficiency and excess activated the activities of caspase-3 and -9 both in vivo and in vitro, 484 
which would in turn catalyze the specific cleavage of cellular apoptotic proteins [50], and caused the 485 
occurrence of apoptosis [51]. Similarly, previous studies indicated Met deficient diets could change 486 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
21 
 
the levels of lipid accumulation in rodents by influencing the activities of caspase [52,53]. In addition, 487 
the potential link between apoptosis and lipid metabolism has been postulated in other study [19]. 488 
Thus, we speculate the apoptotic mediator (caspases) played a bridge role for apoptosis mediating 489 
lipid metabolism. In addition, it is worthy to point out that in the present study, although other factors 490 
(such as stress) may mediate the Met deficiency and excess-induced occurrence of apoptosis, the 491 
majority of proteins involved in apoptosis were increased following dietary Met deficiency or excess. 492 
Taken together, these results suggested that both dietary Met deficiency and excess activated upstream 493 
regulators of apoptosis and caused aberrant hepatic lipid metabolism in P. fulvidraco.  494 
One of objectives of the current study was to explore the mechanism by which upstream 495 
regulators of apoptosis mediated the Met-induced changes in lipid metabolism. To this end, specific 496 
caspase inhibitors Z-VAD-FMK were used. Our current study found that Z-VAD-FMK markedly 497 
alleviated the Met deficiency- and excess-activated apoptosis pathways in P. fulvidraco, similar to 498 
those in mammalian cells [54]. Importantly, the current study also showed that upstream regulators of 499 
apoptosis mediated the Met deficiency- and excess-induced changes in hepatic lipid metabolism since 500 
Z-VAD-FMK markedly attenuated the Met deficiency- and excess-induced effects on gene 501 
transcription and enzymatic activity involved in hepatic lipid metabolism. To our knowledge, very 502 
limited information was available on the role of apoptosis in hepatic lipid metabolism, and involved in 503 
FAS and CPT-1 [55,56]. Additionally, Huang et al [19] pointed out that bioactive lipid molecules 504 
promoted apoptosis via the intrinsic pathway by modulating mitochondrial membrane permeability 505 
and activating different enzymes including caspases. Thus, the present study demonstrated that 506 
upstream regulators of apoptosis were involved in the Met deficiency- and excess-induced 507 
dysregulation of hepatic lipid metabolism in fish. 508 
The mechanisms by Met deficiency- and excess-activating apoptosis may be multifactorial and 509 
regulated by multiple signal transduction pathways. In mammals, studies indicated that 510 
PI3K/AKT-TOR inhibition [57], the activation of cAMP/PKA/CREB and LKB1/AMPK-FOXO 511 
[58,59], would contribute to the occurrence of apoptosis, in agreement with the present in vitro 512 
experiments. Thus, the present study indicated that three signaling pathways mediated Met deficiency- 513 
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and excess-induced apoptosis in yellow catfish. Moreover, the PI3K/AKT-TOR inhibition, and 514 
cAMP/PKA/CREB and LKB1/AMPK-FOXO activation were markedly alleviated by LY294002, H89 515 
and Compound C, respectively; the dysregulation of hepatic lipid metabolism induced by Met 516 
deficiency or Met excess were also significantly attenuated. These observations indicated that the 517 
PI3K/AKT-TOR, cAMP/PKA/CREB and LKB1/AMPK-FOXO pathways mediated the Met 518 
deficiency- and excess-induced changes in hepatic lipid metabolism. Similarly, our recent studies also 519 
suggested that these pathways were involved in lipid metabolism in P. fulvidraco [22,26,28]. Here, 520 
considering the involvement of apoptosis in Met deficiency- and excess-induced changes of hepatic 521 
lipid metabolism, the present study indicated that the three pathways mediated Met deficiency- and 522 
excess-induced apoptosis, providing a mechanism for the aberrant lipid metabolism induced by 523 
imbalanced Met in yellow catfish. Interestingly, we also revealed that Met deficiency or excess 524 
modulated hepatic lipid metabolism via different upstream pathways: (i) Met deficiency via 525 
LKB1/AMPK-FOXO pathway, and (ii) Met excess via PI3K/AKT-TOR and cAMP/PKA/CREB 526 
pathways. Similarly, Yen et al. [10] showed that different nutrient status could differentially induce 527 
apoptosis in different upstream signals. Meanwhile, the present study also indicated that another 528 
inhibitor of PI3K/AKT, wortmannin, did not inhibit but  PI3K/AKT-TOR pathway. This result 529 
implied that wortmannin may involve  Met-induced apoptosis independent of PI3K pathway, similar 530 
to these by Wang et al. [60] and Yan et al. [61]. Thus, taken together, for the first time, we found that 531 
two distinct signaling axis existed in the effects of dietary Met on hepatic lipid metabolism in P. 532 
fulvidraco. 533 
Because of whole-genome duplication in teleost fishes [62], one should keep cautious when 534 
extrapolating the results in the fish to mammals. We therefore compared the similarities in the process 535 
of upstream regulators of apoptosis mediating imbalanced Met-induced changes of hepatic lipid 536 
metabolism between yellow catfish and human cells. In the present study, two main similarities 537 
existed: (i) Met deficiency and excess activated upstream regulators of apoptosis and caused 538 
dysregulation of lipid metabolism both in P. fulvidraco primary hepatocytes and in HepG2 cells, (ii) 539 
upstream regulators of apoptosis were involved in Met deficiency or excess-induced changes of lipid 540 
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metabolism both in P. fulvidraco primary hepatocytes and in HepG2 cells. Indeed, the conserved 541 
effects of imbalanced Met on apoptosis have been found in various cell and species [63]. Furthermore, 542 
these findings confirmed an evolutionary conserved role of upstream regulators of apoptosis in 543 
regulation of lipid metabolism, which also supported our hypothesis. However, several distinctions 544 
were observed: (i) Met deficiency and excess induced TG accumulation via different processes of lipid 545 
metabolism between P. fulvidraco and HepG2 cell, and (ii) upstream regulators of apoptosis 546 
modulated lipid metabolism via different pathways between P. fulvidraco and HepG2 cell. Similarly, 547 
Yen et al. [10] suggested that essential nutrient deficiency and excess activated different upstream 548 
apoptotic pathways that ultimately converged on a common execution pathway. These findings 549 
suggested the mechanisms of apoptosis-related signaling pathways regulating lipid metabolism have 550 
species-specific responses. 551 
In conclusion, the present study clearly indicated that both dietary Met deficiency and excess 552 
evoked upstream regulators of apoptosis and induced the changes of hepatic lipid metabolism in fish. 553 
Upstream regulators of apoptosis mediated the Met deficiency- and excess-induced changes of hepatic 554 
lipid metabolism. Moreover, two distinct signaling axis were involved in Met-induced changes of 555 
hepatic lipid metabolism. We also observed the similarities of the mechanism involved in the upstream 556 
regulators of apoptosis mediating Met-induced changes of lipid metabolism between P. fulvidraco and 557 
HepG2 cell (Supplementary Fig.10; Fig. 7). These findings highlight the importance of the upstream 558 
regulators of apoptosis in the regulation of Met-induced changes of lipid metabolism. 559 
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 757 
Figure captions 758 
FIGURE 1. Pathway enrichment analysis of DEPs involved in signal transduction, apoptosis and 759 
lipid metabolism in liver of P. fulvidraco fed different levels of dietary Met. (A) Volcano plots of 760 
DEPs from Met deficiency vs adequate Met. (B) Histogram showing numbers of DEPs from Met 761 
deficiency vs adequate Met. DEPs were indicated in red (increase) and green (reduction). Black meant 762 
proteins that were not differentially expressed. (C) Statistics of pathway enrichment of DEPs from Met 763 
deficiency vs adequate Met. Rich Factor was the ratio of the number of DEPs annotated in this 764 
pathway to all protein number annotated in this pathway. Greater Rich Factor meant greater 765 
intensiveness. (D, E and F) From Met excess vs adequate Met, volcano plots of DEPs, histogram 766 
showing numbers of DEPs, and statistics of pathway enrichment of DEPs, respectively. 767 
FIGURE 2. Dietary Met deficiency or excess induced the changes of upstream regulators of 768 
apoptosis in liver of P. fulvidraco. (A) Liver ultrastructure (TEM, original magnification ×10000, 769 
bars 1 µm) of P. fulvidraco fed different levels of dietary Met. Abbreviation: endoplasmic reticulum 770 
(er); hepatocyte nucleus (N); nucleolus (n); chromatin margination (marg); nuclear convolution (con). 771 
Liver cells of fish fed adequate dietary Met, showing the typical appearance of hepatocyte nucleus and 772 
nucleolus. Hepatocytes in Met deficiency and excess groups showed the chromatin margination and 773 
nuclear convolution. (C and D) Effect of dietary Met deficiency or excess on the transcription of genes 774 
involved in upstream regulators of apoptosis (PI3K/AKT-TOR, cAMP/PKA/CREB and 775 
LKB1/AMPK-FoxO). mRNA transcription values were normalized to β-actin and GAPDH expressed 776 
as a ratio of the control on adequate Met (control = 1). (E) Dietary Met deficiency and excess 777 
increased the activities of caspase-3 and -9. Values are mean ± SEM (n = 3 replicate tanks, and for 778 
each tank, three fish were sampled for gene transcription and four fish for activities of Caspase-3 and 779 
-9). Asterisks indicate significant differences between Met deficiency or excess and adequate Met 780 
group (P < 0.05).  781 
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FIGURE 3. Dietary Met deficiency or excess caused aberrant lipid metabolism in liver of P. 782 
fulvidraco. (A) Liver histology (H&E) and histochemistry (oil-red O staining) (original magnification 783 
×200, bars 50μm) of P. fulvidraco fed different levels of dietary Met. Abbreviation: hepatocytes (he); 784 
vacuoles (va); pyknotic nuclei (pn). Lipid was red-colored and nuclei-blue colored after staining with 785 
oil-red O. Dietary Met deficiency and excess increased the amount of vacuoles (H&E) and lipid 786 
droplets (oil-red O staining). (B and C) The relative areas, analyzed by Image-Pro Plus 6.0, for hepatic 787 
vacuoles (H&E) and lipid droplets (oil-red O staining) of P. fulvidraco fed different levels of dietary 788 
Met. (D, E and F) Effects of dietary Met deficiency or excess on the activities of FAS, HSL and CPT-1 789 
(D), and the contents of APO-A1 and APO-B (E) and TG (F), in liver of P. fulvidraco. (G) Effect of 790 
dietary Met deficiency or excess on the transcription of genes involved in lipogenesis, lipolysis, 791 
oxidation and lipid transport. mRNA transcription values were normalized to β-actin and GAPDH 792 
expressed as a ratio of the control on adequate Met (control = 1). Values are mean ± SEM (n = 3 793 
replicate tanks, and for each tank, three fish were sampled for gene transcription and four fish for 794 
H&E, oil-red O staining, the activities of FAS, HSL and CPT-1 and the contents of APO-A1, APO-B 795 
and TG). Different letters indicated significant differences among groups (P < 0.05). 796 
FIGURE 4. The involvement of upstream regulators of apoptosis in imbalance Met-induced 797 
aberrant lipid metabolism in hepatocyte of P. fulvidraco in vitro. (A, B, C and D) Met deficiency or 798 
excess-induced increase of the FITC+/PI+ positive rate (B), apoptosis index (C), and rates of apoptosis 799 
(D) were markedly alleviated by Z-VAD.FMK in primary hepatocyte of P. fulvidraco in vitro. (E) Met 800 
deficiency or excess-induced change in the transcription of genes involved in upstream regulators of 801 
apoptosis were markedly attenuated by Z-VAD.FMK in primary hepatocyte of P. fulvidraco in vitro. 802 
mRNA transcription values were normalized to β-actin and GAPDH expressed as a ratio of the control 803 
on adequate Met (control = 1). (F) Z-VAD.FMK significantly attenuated the Met deficiency or 804 
excess-induced increase of caspase-3 and -9 activities. (G) Met deficiency or excess-induced change 805 
in the mRNA abundances of genes involved in lipid metabolism were markedly attenuated by 806 
Z-VAD.FMK in primary hepatocyte of P. fulvidraco. mRNA transcription values were normalized to 807 
β-actin and GAPDH expressed as a ratio of the control on adequate Met (control = 1). (H, I and J) 808 
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Effect of Z-VAD.FMK on Met deficiency or excess-induced change in the activities of FAS, HSL and 809 
CPT-1, and the contents of APO-A1 and APO-B and TG. Values are mean ± SEM (n = 3 independent 810 
biological experiments). Different letters indicated significant differences among groups (P < 0.05). 811 
FIGURE 5. LKB1/AMPK-FOXO pathway which regulates apoptosis is involved in imbalanced 812 
Met-induced changes of lipid metabolism in hepatocytes of P. fulvidraco. (A) Met excess-induced 813 
change in the transcription of genes involved in LKB1/AMPK-FOXO pathway were markedly 814 
attenuated by Compound C. mRNA transcription values were normalized to β-actin and GAPDH 815 
expressed as a ratio of the control on adequate Met (control = 1). (B) Compound C significantly 816 
attenuated the Met excess-induced increase of pAMPK content. (C, D and E) Compound C 817 
significantly attenuated the Met excess-induced increase of apoptosis rates (C and D), caspase-3 and 818 
-9 activities (E). (F) Met excess-induced change in the transcription of genes involved in apoptosis 819 
signaling pathways were markedly attenuated by Compound C. mRNA transcription values were 820 
normalized to β-actin and GAPDH expressed as a ratio of the control on adequate Met (control = 1). 821 
(G) Compound C significantly attenuated the Met excess-induced increase of TG content. (H) Met 822 
excess-induced change in the mRNA abundances of genes involved in lipid metabolism were 823 
markedly attenuated by Compound C. mRNA transcription values were normalized to β-actin and 824 
GAPDH expressed as a ratio of the control on adequate Met (control = 1). Values are mean ± SEM (n 825 
= 3 independent biological experiments). Different letters indicated significant differences among 826 
groups (P < 0.05). 827 
FIGURE 6. The involvement of upstream regulators of apoptosis in imbalanced Met-induced 828 
changes of lipid metabolism in HepG2 cells line. (A, B, C and D) Met deficiency or excess-induced 829 
increase of the FITC+/PI+ positive rate (B), apoptosis index (C), and rates of apoptosis (D) were 830 
markedly alleviated by Z-VAD.FMK in HepG2 cells line in vitro. (E) Met deficiency or 831 
excess-induced change in the transcription of genes involved in upstream regulators of apoptosis were 832 
markedly attenuated by Z-VAD.FMK in HepG2 cells line in vitro. mRNA transcription values were 833 
normalized to β-actin and GAPDH expressed as a ratio of the control on adequate Met (control = 1). 834 
(F) Z-VAD.FMK significantly attenuated the Met deficiency or excess-induced increase of caspase-3 835 
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and -9 activities. (G) Met deficiency or excess-induced change in the mRNA abundances of genes 836 
involved in lipid metabolism were markedly attenuated by Z-VAD.FMK in HepG2 cells line in vitro. 837 
mRNA transcription values were normalized to β-actin and GAPDH expressed as a ratio of the control 838 
on adequate Met (control = 1). (H, I and J) Effect of Z-VAD.FMK on Met deficiency or 839 
excess-induced change in the activities of FAS, HSL and CPT-1, and the contents of APO-A1 and 840 
APO-B and TG. Values are mean ± SEM (n = 3 independent biological experiments). Different letters 841 
indicated significant differences among groups (P < 0.05). 842 
FIGURE 7. Graphical conclusions for the mechanism of upstream regulators of apoptosis 843 
mediating methionine deficiency or excess-induced changes of hepatic lipid metabolism in P. 844 
fulvidraco and HepG2 cells line. The yellow words meant the significant influence by Met deficiency; 845 
the blue words meant the significant influence by Met excess; the black word meant significant 846 
influences by both Met deficiency and excess. The up and down arrows meant the increase and the 847 
reduction, respectively. 848 
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Fig. 5. 884 
 885 
 886 
 887 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
40 
 
Fig. 6. 888 
A
E F
G
H
I
J
3.87 %
1.68 %
45.56 %
1.02 %
50.86 %
1.38 %
19.58 %
0.99 %
18.23 %
1.26 %
B C D
 889 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
41 
 
Fig. 7. 890 
 891 
  
Supplementary Material
Click here to download Supplementary Material: Supplementary Tables and Figures.doc
